Alprazolam retard in the treatment of pathological anxiety. Naturalistic study
✍ Scribed by J. de la Gándara; O. Sanz; A. Varona; P. Such
- Book ID
- 118601546
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 313 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0924-977X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A multicentre, double-blind, randomized trial compared the ecacy of a sustained-release formulation of alprazolam with bromazepam in the treatment of generalized anxiety. One hundred and twenty-one outpatients were randomly assigned to three weeks of active treatment with alprazolam SR (2 mg once da
In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage